论文部分内容阅读
用放射免疫分析方法测定急性肝炎、肝癌患者血清T_3、T_4含量分析临床价值,现将结果报告如下。 资料和方法 一、临床资料:急性肝炎组:为临床症状、体征、实验检查肝功能异常,ALT达250～640赖氏单位的明显升高患者126例(男性67例,女性59例),年龄6～72岁,平均21.5岁。肝癌组:均经B超、CT检查及AFP RIA>400μg/L等确诊,共31例(男性18例,女性13例),年龄26～64岁,平均42岁。正常对照组:为健康体检献血员63例(男性24人,女性39人),年龄24～42岁,均排除甲状腺及肝脏疾病史。 二、方法:T_3、T_4、AFP RIA kit由上海放射免
Radioimmunoassay method for the determination of acute hepatitis, liver cancer serum T_3, T_4 content analysis of clinical value, the results are reported as follows. DATA AND METHODS A. Clinical data: Acute hepatitis group: clinical symptoms and signs, abnormal liver function tests, 126 patients with ALT up to 250 ~ 640 units (67 males and 59 females), age 6 to 72 years old, average 21.5 years old. Liver cancer group: 31 cases (18 males and 13 females) were diagnosed by B-mode ultrasound, CT examination and AFP RIA> 400μg / L, with a mean age of 42 years. Normal control group: 63 healthy blood donors (24 males and 39 females), aged 24 to 42 years old, all exclude the history of thyroid and liver disease. Second, methods: T_3, T_4, AFP RIA kit radioactive from Shanghai